The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/96922 |
Resumo: | OBJECTIVE: Ovarian mucinous metastases commonly present as the first sign of the disease and are capable of simulating primary tumors. Our aim was to investigate the role of intratumoral lymphatic vascular density together with other surgical-pathological features in distinguishing primary from secondary mucinous ovarian tumors. METHODS: A total of 124 cases of mucinous tumors in the ovary (63 primary and 61 metastatic) were compared according to their clinicopathological features and immunohistochemical profiles. The intratumoral lymphatic vascular density was quantified by counting the number of vessels stained by the D2-40 antibody. RESULTS: Metastases occurred in older patients and were associated with a higher proportion of tumors smaller than 10.0 cm; bilaterality; extensive necrosis; extraovarian extension; increased expression of cytokeratin 20, CDX2, CA19.9 and MUC2; and decreased expression of cytokeratin 7, CA125 and MUC5AC. The lymphatic vascular density was increased among primary tumors. However, after multivariate analysis, the best predictors of a secondary tumor were a size of 10.0 cm or less, bilaterality and cytokeratin 7 negativity. Lack of MUC2 expression was an important factor excluding metastasis. CONCLUSIONS: The higher intratumoral lymphatic vascular density in primary tumors when compared with secondary lesions suggests differences in the microenvironment. However, considering the differential diagnosis, the best discriminator of a secondary tumor is the combination of tumor size, laterality and the pattern of expression of cytokeratin 7 and MUC2. |
id |
USP-19_a5bb56d628310337ff464a7616eb682c |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/96922 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors OBJECTIVE: Ovarian mucinous metastases commonly present as the first sign of the disease and are capable of simulating primary tumors. Our aim was to investigate the role of intratumoral lymphatic vascular density together with other surgical-pathological features in distinguishing primary from secondary mucinous ovarian tumors. METHODS: A total of 124 cases of mucinous tumors in the ovary (63 primary and 61 metastatic) were compared according to their clinicopathological features and immunohistochemical profiles. The intratumoral lymphatic vascular density was quantified by counting the number of vessels stained by the D2-40 antibody. RESULTS: Metastases occurred in older patients and were associated with a higher proportion of tumors smaller than 10.0 cm; bilaterality; extensive necrosis; extraovarian extension; increased expression of cytokeratin 20, CDX2, CA19.9 and MUC2; and decreased expression of cytokeratin 7, CA125 and MUC5AC. The lymphatic vascular density was increased among primary tumors. However, after multivariate analysis, the best predictors of a secondary tumor were a size of 10.0 cm or less, bilaterality and cytokeratin 7 negativity. Lack of MUC2 expression was an important factor excluding metastasis. CONCLUSIONS: The higher intratumoral lymphatic vascular density in primary tumors when compared with secondary lesions suggests differences in the microenvironment. However, considering the differential diagnosis, the best discriminator of a secondary tumor is the combination of tumor size, laterality and the pattern of expression of cytokeratin 7 and MUC2. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/9692210.6061/clinics/2014(10)02Clinics; Vol. 69 No. 10 (2014); 660-665Clinics; v. 69 n. 10 (2014); 660-665Clinics; Vol. 69 Núm. 10 (2014); 660-6651980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/96922/96002Copyright (c) 2015 Clinicsinfo:eu-repo/semantics/openAccessAlmeida, Bernardo Gomes de Lacerda Bacchi, Carlos E. Carvalho, Jesus P. Ferreira, Cristiane R. Carvalho, Filomena M. 2015-03-27T17:35:38Zoai:revistas.usp.br:article/96922Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2015-03-27T17:35:38Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
title |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
spellingShingle |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors Almeida, Bernardo Gomes de Lacerda |
title_short |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
title_full |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
title_fullStr |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
title_full_unstemmed |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
title_sort |
The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors |
author |
Almeida, Bernardo Gomes de Lacerda |
author_facet |
Almeida, Bernardo Gomes de Lacerda Bacchi, Carlos E. Carvalho, Jesus P. Ferreira, Cristiane R. Carvalho, Filomena M. |
author_role |
author |
author2 |
Bacchi, Carlos E. Carvalho, Jesus P. Ferreira, Cristiane R. Carvalho, Filomena M. |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Almeida, Bernardo Gomes de Lacerda Bacchi, Carlos E. Carvalho, Jesus P. Ferreira, Cristiane R. Carvalho, Filomena M. |
description |
OBJECTIVE: Ovarian mucinous metastases commonly present as the first sign of the disease and are capable of simulating primary tumors. Our aim was to investigate the role of intratumoral lymphatic vascular density together with other surgical-pathological features in distinguishing primary from secondary mucinous ovarian tumors. METHODS: A total of 124 cases of mucinous tumors in the ovary (63 primary and 61 metastatic) were compared according to their clinicopathological features and immunohistochemical profiles. The intratumoral lymphatic vascular density was quantified by counting the number of vessels stained by the D2-40 antibody. RESULTS: Metastases occurred in older patients and were associated with a higher proportion of tumors smaller than 10.0 cm; bilaterality; extensive necrosis; extraovarian extension; increased expression of cytokeratin 20, CDX2, CA19.9 and MUC2; and decreased expression of cytokeratin 7, CA125 and MUC5AC. The lymphatic vascular density was increased among primary tumors. However, after multivariate analysis, the best predictors of a secondary tumor were a size of 10.0 cm or less, bilaterality and cytokeratin 7 negativity. Lack of MUC2 expression was an important factor excluding metastasis. CONCLUSIONS: The higher intratumoral lymphatic vascular density in primary tumors when compared with secondary lesions suggests differences in the microenvironment. However, considering the differential diagnosis, the best discriminator of a secondary tumor is the combination of tumor size, laterality and the pattern of expression of cytokeratin 7 and MUC2. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/96922 10.6061/clinics/2014(10)02 |
url |
https://www.revistas.usp.br/clinics/article/view/96922 |
identifier_str_mv |
10.6061/clinics/2014(10)02 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/96922/96002 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2015 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2015 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 69 No. 10 (2014); 660-665 Clinics; v. 69 n. 10 (2014); 660-665 Clinics; Vol. 69 Núm. 10 (2014); 660-665 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222761663070208 |